For citations:
Misyurin V.A., Kalenichenko D.V., Rudakova A.A., Finashutina Yu.P., Lyzhko N.A., Tikhonova V.V., Kesaeva L.A., Solopova O.N., Misyurina A.Е., Velikanov A.N., Baryshnikovа M.А., Misyurin A.V. Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib. Advances in Molecular Oncology. 2018;5(4):131-134. (In Russ.) https://doi.org/10.17650/2313-805X-2018-5-4-131-134
Email this article 